| Paula Shireman, MD | |
|
7703 Floyd Curl Dr, Mc 7977, San Antonio, TX 78229-3901 | |
| (210) 257-1400 | |
| (210) 257-1428 |
| Full Name | Paula Shireman |
|---|---|
| Gender | Female |
| Speciality | Vascular Surgery |
| Experience | 34 Years |
| Location | 7703 Floyd Curl Dr, San Antonio, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043229081 | NPI | - | NPPES |
| 043859001 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | K8838 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Aandm University System Health Science Center | 8224008644 | 35 |
News Archive
Lexicon Pharmaceuticals, Inc. announced today that it is progressing into the placebo-controlled portion of its Phase 2 clinical trial of LX4211 in patients with type 1 diabetes, having successfully completed the open-label, pioneer portion of the trial.
A recent journal article presents evidence that suggests that the course of treatment that a doctor chooses to treat a breast cancer patient may play a larger role in expected outcomes than was previously believed. The Journal of the National Cancer Institute's article (online 01/03/2011; print 01/19/2011) Breast Cancer Outcome: Your Doctor Matters examines variations in outcomes from surgeon to surgeon.
Mouse models of human oral cancer treated with an agent called capsazepine showed dramatic tumor shrinkage without damage to surrounding tissues, researchers from the School of Dentistry and School of Medicine at The University of Texas Health Science Center at San Antonio found.
Research presented at Digestive Disease Week explores new methods for managing digestive health through diet and lifestyle.
World Vision commends the U.S. Senate for approving increases for hunger and developmental assistance for fiscal years 2008 and 2009 in the Supplemental Appropriations Act, including $850 million in the first year to address the global food crisis.
› Verified 3 days ago
| Entity Name | University Of Texas Health Science Center At San Antonio |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720051717 PECOS PAC ID: 0042128548 Enrollment ID: O20040607000664 |
News Archive
Lexicon Pharmaceuticals, Inc. announced today that it is progressing into the placebo-controlled portion of its Phase 2 clinical trial of LX4211 in patients with type 1 diabetes, having successfully completed the open-label, pioneer portion of the trial.
A recent journal article presents evidence that suggests that the course of treatment that a doctor chooses to treat a breast cancer patient may play a larger role in expected outcomes than was previously believed. The Journal of the National Cancer Institute's article (online 01/03/2011; print 01/19/2011) Breast Cancer Outcome: Your Doctor Matters examines variations in outcomes from surgeon to surgeon.
Mouse models of human oral cancer treated with an agent called capsazepine showed dramatic tumor shrinkage without damage to surrounding tissues, researchers from the School of Dentistry and School of Medicine at The University of Texas Health Science Center at San Antonio found.
Research presented at Digestive Disease Week explores new methods for managing digestive health through diet and lifestyle.
World Vision commends the U.S. Senate for approving increases for hunger and developmental assistance for fiscal years 2008 and 2009 in the Supplemental Appropriations Act, including $850 million in the first year to address the global food crisis.
› Verified 3 days ago
| Entity Name | Texas A&m University System Health Science Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063699312 PECOS PAC ID: 8224008644 Enrollment ID: O20040802001578 |
News Archive
Lexicon Pharmaceuticals, Inc. announced today that it is progressing into the placebo-controlled portion of its Phase 2 clinical trial of LX4211 in patients with type 1 diabetes, having successfully completed the open-label, pioneer portion of the trial.
A recent journal article presents evidence that suggests that the course of treatment that a doctor chooses to treat a breast cancer patient may play a larger role in expected outcomes than was previously believed. The Journal of the National Cancer Institute's article (online 01/03/2011; print 01/19/2011) Breast Cancer Outcome: Your Doctor Matters examines variations in outcomes from surgeon to surgeon.
Mouse models of human oral cancer treated with an agent called capsazepine showed dramatic tumor shrinkage without damage to surrounding tissues, researchers from the School of Dentistry and School of Medicine at The University of Texas Health Science Center at San Antonio found.
Research presented at Digestive Disease Week explores new methods for managing digestive health through diet and lifestyle.
World Vision commends the U.S. Senate for approving increases for hunger and developmental assistance for fiscal years 2008 and 2009 in the Supplemental Appropriations Act, including $850 million in the first year to address the global food crisis.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paula Shireman, MD 7703 Floyd Curl Dr, Mc 7977, San Antonio, TX 78229-3901 Ph: (210) 257-1400 | Paula Shireman, MD 7703 Floyd Curl Dr, Mc 7977, San Antonio, TX 78229-3901 Ph: (210) 257-1400 |
News Archive
Lexicon Pharmaceuticals, Inc. announced today that it is progressing into the placebo-controlled portion of its Phase 2 clinical trial of LX4211 in patients with type 1 diabetes, having successfully completed the open-label, pioneer portion of the trial.
A recent journal article presents evidence that suggests that the course of treatment that a doctor chooses to treat a breast cancer patient may play a larger role in expected outcomes than was previously believed. The Journal of the National Cancer Institute's article (online 01/03/2011; print 01/19/2011) Breast Cancer Outcome: Your Doctor Matters examines variations in outcomes from surgeon to surgeon.
Mouse models of human oral cancer treated with an agent called capsazepine showed dramatic tumor shrinkage without damage to surrounding tissues, researchers from the School of Dentistry and School of Medicine at The University of Texas Health Science Center at San Antonio found.
Research presented at Digestive Disease Week explores new methods for managing digestive health through diet and lifestyle.
World Vision commends the U.S. Senate for approving increases for hunger and developmental assistance for fiscal years 2008 and 2009 in the Supplemental Appropriations Act, including $850 million in the first year to address the global food crisis.
› Verified 3 days ago
Anas Mouchli, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 7703 Floyd Curl Dr # Mc7742, San Antonio, TX 78229 Phone: 210-567-5711 | |
Dr. Agustin Cornejo Esquerra, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 311 Camden St Ste 409, San Antonio, TX 78215 Phone: 210-228-9605 Fax: 210-228-9632 | |
Dr. Robert P Thomas, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 4499 Medical Dr, Suite 347, San Antonio, TX 78229 Phone: 210-615-8757 Fax: 210-615-8789 | |
Grant Harrison Gershner, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 7703 Floyd Curl Dr, San Antonio, TX 78229 Phone: 210-567-7000 | |
Dr. Donald Howard Jenkins, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4502 Medical Dr, San Antonio, TX 78229 Phone: 210-358-4000 | |
Dr. Donald David Dilworth, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 8715 Village Dr, Suite 608, San Antonio, TX 78217 Phone: 210-657-2100 Fax: 210-675-2110 | |
Marlin W Causey, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3851 Roger Brooke Dr, San Antonio, TX 78234 Phone: 210-539-9360 |